British pharma company GSK pauses diversity work citing Trump orders London-based FTSE 100 firm reviewing its policies, saying it is obliged to comply because US is its No 1 market The Guardian - UK · Feb 28, 2025
GSK could double CEO Emma Walmsley's pay to $27 million The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor. Fortune · Feb 28, 2025
GSK boss Emma Walmsley’s pay could rise to nearly £22m in three years’ time UK pharmaceutical companies aim to put executive pay on par with US rivals’ but package will depend on share price The Guardian - UK · Feb 27, 2025
Women hold almost 45% of seats on FTSE 100 boards, report says New high tempered by dip in number of female CEOs at 100 biggest listed firms to fewer than 10 last year The Guardian - UK · Feb 25, 2025
Drug firm GSK delivers a syringe full of crowd-pleasers Pharmaceuticals company’s higher dividend, upgrade to revenues and share buyback suggest its drugs pipeline is flowing nicely The Guardian - UK · Feb 5, 2025
GSK lifts long-term sales targets on new drug pipeline It came as the boss of the London-listed firm cheered an ‘excellent’ performance in 2024. Evening Standard · Feb 5, 2025
FTSE 100 Live 30 October: Next forecasts £1bn profit, GSK vaccine sales weakness hits shares A £1 billion profits landmark for Next and strong trading at Standard Chartered today provided FTSE 100 cheer during another painful session for GSK investors. Evening Standard · Oct 30, 2024
GSK’s health is improving. Shame about the legal heartburn Emma Walmsley’s overhaul seems to be delivering the goods even if US worries have left the share price becalmed The Guardian - UK · Jul 31, 2024
GlaxoSmithKline boss’s pay package jumps 50% to £12.7m Emma Walmsley’s deal, with a high share bonus payout, makes her one of top-paid CEOs in FTSE 100 The Guardian - UK · Mar 1, 2024
Obesity drug boom pushes Novo Nordisk shares to record high Market value of Danish drugmaker behind Wegovy and Ozempic tops $500bn as demand soars The Guardian - UK · Jan 31, 2024
FTSE 100 bosses ‘given average pay rise of £500,000 in 2022’ CEOs received average increase of 16% while pay of many working for them failed to keep up with inflation The Guardian - UK · Aug 22, 2023
Tech spending: The companies on London’s blue chip index exploring AI A host of FTSE 100 companies are among businesses planning to invest in AI Evening Standard · Jul 5, 2023
GSK CEO Emma Walmsley says A.I. could improve Big Pharma's most 'profound' challenge: R&D inefficiency "When we talk about health care costs, the single biggest thing we can do is innovate more.” Fortune · Jun 1, 2023
GSK’s CEO says you need thick skin if you’re going to step into the C-suite Emma Walmsley reflects on what it takes to lead a company through a turnaround. Fortune · May 31, 2023
Fortune · May 30, 2023 Why GSK's Emma Walmsley 'violently rejects' the idea of 'superhero' CEOs In her mind, leadership is about inspiring collaboration.
The Guardian - UK · Apr 26, 2023 New CBI boss says she is ‘profoundly sorry’ to women let down by group Rain Newton-Smith’s tweets came on day she became director general at Confederation of British Industry
The Guardian - UK · Feb 1, 2023 GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas
Evening Standard · Dec 12, 2022 GSK to move back to central London with new HQ Six floor office building on New Oxford Street will be workplace for 3,000 staff including CEO
Daily Mirror · Aug 27, 2022 Meet Britain's 10 highest paid fat cats who pocketed more than £100m last year That means they are now getting 109 times more in their wage slips than the typical British worker - up from 79 times in the previous year
Evening Standard · Jul 4, 2022 Gender pay gap widens in FTSE100 boardrooms Emma Walmsley is only woman in top 50 best paid Footsie directors
The Guardian - UK · Feb 28, 2022 GSK boss upbeat over spin-off of consumer healthcare unit Expected to be the biggest London listing in a decade, the Haleon demerger is scheduled for July
The Guardian - UK · Feb 9, 2022 Noisy activists aside, GSK investors backed Walmsley and her strategy The ‘step-change’ in growth for the core pharma division has barely started, but the CEO is secure for now
Evening Standard · Feb 9, 2022 Under pressure GlaxoSmithKline promises ‘landmark’ year as its outshone by Pfizer GlaxoSmithKline remained under pressure today after so-so results that drew unfavourable comparisons with US rival Pfizer.
The Guardian - UK · Feb 9, 2022 GSK boss pledges ‘landmark year’ as pharma firm pursues demerger Results better than forecast but Emma Walmsley is under pressure from activist investors clamouring for change
The Guardian - UK · Jan 19, 2022 GSK’s top scientist jumps ship in new blow for pharmaceutical firm Hal Barron to leave just as pressure builds on GSK to come up with new medicines